LARRY LIPSHULTZ to Cohort Studies
This is a "connection" page, showing publications LARRY LIPSHULTZ has written about Cohort Studies.
Connection Strength
0.627
-
Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54.
Score: 0.091
-
Association Between Testosterone Supplementation Therapy and Thrombotic Events in Elderly Men. Urology. 2015 Aug; 86(2):283-5.
Score: 0.064
-
Vasectomy reversal outcomes in men previously on testosterone supplementation therapy. Urology. 2014 Dec; 84(6):1335-40.
Score: 0.060
-
Hypogonadal symptoms are associated with different serum testosterone thresholds in middle-aged and elderly men. Urology. 2014 Dec; 84(6):1378-82.
Score: 0.060
-
Testosterone therapy and mortality risk. Int J Impot Res. 2015 Mar-Apr; 27(2):46-8.
Score: 0.059
-
Semen quality, infertility and mortality in the USA. Hum Reprod. 2014 Jul; 29(7):1567-74.
Score: 0.058
-
Impact of the 2012 American Urological Association vasectomy guidelines on post-vasectomy outcomes. J Urol. 2014 Jan; 191(1):169-74.
Score: 0.055
-
Increased risk of cancer among azoospermic men. Fertil Steril. 2013 Sep; 100(3):681-5.
Score: 0.055
-
The relationship between anogenital distance and the androgen receptor CAG repeat length. Asian J Androl. 2013 Mar; 15(2):286-9.
Score: 0.053
-
Sperm counts and sperm sex ratio in male infertility patients. Asian J Androl. 2012 Sep; 14(5):683-6.
Score: 0.052
-
Increased Risk of Incident Disease in Men with Peyronie's Disease: Analysis of U.S. Claims Data. J Sex Med. 2018 06; 15(6):894-901.
Score: 0.019